# Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

> **NCT03478280** · PHASE4 · UNKNOWN · sponsor: **Aarhus University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Brodalumab
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03478280
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-15
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478280, "Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03478280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*